Yixi Biotech
Nanjing
About Yixi Biotech
Yixi Biotech is a provider of solutions for the intestinal microbiology sector, focusing on providing solutions for the intestinal microbiology sector. It mainly distributes three research and development pipelines for diabetes, depression and tumor reconstitution after tumor chemotherapy, focusing on intestinal microbes and human body. Research on health mechanisms, research on intestinal microecology and intestinal immune microenvironment interaction mechanisms and disease intervention strategies, and research and development of alternative treatment protocols, synthetic biological strains and drugs for the treatment of intestinal microbial diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $41.6M
- Funding stage: Early Stage Venture
- Last round: Series A (Aug 2025)
- Website: yixilife.com
- Phone: 0512-62906278
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/yixi-biotech-108026 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.